Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous

Viktor Klancik1,2,3, Ladislav Pesl3, Marek Neuberg4

  • 1Third Faculty of Medicine, Charles University, Prague, Ruska 2411, 100 00, Czech Republic.

Insights

Cardiovascular diseases are the leading cause of death after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) up to 12 years. A new model helps identify patients needing aggressive secondary prevention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Long-term outcomes following primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) are not well-defined.
  • Existing risk-stratification systems for post-pPCI patients are lacking for routine clinical use.

Purpose of the Study:

  • To describe long-term mortality beyond 5 years after pPCI for STEMI.
  • To identify predictors of long-term cardiovascular mortality.
  • To develop a predictive model for cardiovascular death risk stratification.

Main Methods:

  • Retrospective, academic, two-centre analysis of 5263 consecutive STEMI patients treated with pPCI (March 2008 - December 2019).
  • Data collected from prospective local registries and initial hospitalization records.
  • Multivariate analysis and predictive model development using identified mortality predictors.

Main Results:

  • Cardiovascular mortality was the predominant cause of death (65.0%) during long-term follow-up (up to 12 years), with myocardial infarction-associated mortality at 27.2%.
  • Significant predictors for long-term cardiovascular mortality included age, diabetes mellitus, renal insufficiency, heart failure, Killip class, and successful pPCI.
  • A predictive model demonstrated high discrimination (C-statistic = 0.84) for cardiovascular death risk.

Conclusions:

  • Cardiovascular diseases are the primary cause of long-term mortality in Central European patients after pPCI for STEMI.
  • The developed predictive model offers valuable risk stratification, potentially guiding aggressive secondary prevention strategies for high-risk individuals.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
97
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
32
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
219